US 11655248
Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor
granted A61KA61K31/519A61P
Quick answer
US patent 11655248 (Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor) held by Medshine Discovery Inc. expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/519, A61P, A61P35/00